| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
4,589 |
2,239 |
$2.14M |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
1,014 |
472 |
$465K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
7,722 |
4,293 |
$153K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,919 |
3,581 |
$139K |
| 92134 |
|
9,319 |
5,853 |
$77K |
| J9035 |
Injection, bevacizumab, 10 mg |
1,922 |
1,022 |
$37K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,311 |
840 |
$27K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
932 |
734 |
$19K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
61 |
25 |
$19K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
400 |
239 |
$14K |
| 92250 |
|
449 |
287 |
$7K |
| 99222 |
Initial hospital care, per day, moderate complexity |
87 |
57 |
$5K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
54 |
26 |
$2K |
| 92235 |
|
52 |
28 |
$1K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
30 |
15 |
$582.04 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
63 |
52 |
$0.00 |